Ceryle Pharmatech Llp - Due diligence report

A 360° intelligence report on Ceryle Pharmatech Llp: trust score, financial health, credit view, compliance, directors, growth and distress …

2022-01-29 Navi Mumbai, Maharashtra Active
Share
Connect MCP
CP Ceryle Pharmatech Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ceryle Pharmatech Llp — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Ceryle Pharmatech Llp is assessed as Low Risk with a Trust Score of 82/100. Ceryle Pharmatech Llp is an active limited liability partnership incorporated in 2022, operating in the Information Technology sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 06 Oct 2026 from the latest processed filings. Ceryle Pharmatech Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
TEJASHREE RANJIT JADHAV 01234567 Director 01/04/2018 6 yrs Approved
VAISHAKH MADHUKAR CHAVAN 01234567 Director 01/04/2018 6 yrs Approved
RANJIT DHANAJI JADHAV 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Young company (4 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • No financials on record - ask for audited statements.
Banker assessment71/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
31 Jul 2024
Director ceased
NIKHIL RAJENDRA KSHIRSAGAR
29 Jan 2022
Incorporated
Registered with Roc Mumbai Ii
Director appointed
TEJASHREE RANJIT JADHAV (Designated Partner)
Director appointed
VAISHAKH MADHUKAR CHAVAN (Designated Partner)
Director appointed
RANJIT DHANAJI JADHAV (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Domo Engineering Plastics India Private Limited U25199MH2016PTC283082 Thane, Maharashtra
Webele Credit Management Private Limited U67100MH2011PTC223071 Thane, Maharashtra
Reliance Concrete Private Limited U26940MH2011PTC214982 Thane, Maharashtra
Candor Foods Private Limited U51101MH2013PTC246275 Thane, Maharashtra
Lloyd'S Register Industrial Services (India) Private Limited U61100MH1982PTC026147 Thane, Maharashtra
Vidhaan Meraki Quickspace Tech Homes Private Limited U68200MH2024PTC419948 Thane, Maharashtra
Techtron Electronics Private Limited U74999MH2021PTC352990 Thane, Maharashtra
Biztran Solutions Private Limited U72300MH2012PTC226151 Thane, Maharashtra
QUALITY KIOSK SOFTWARE LLP AAH-4090 Thane, Maharashtra
Laban Ceilings And Floorings Private Limited U36100MH2009PTC196905 Thane, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ceryle Pharmatech Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ceryle Pharmatech Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Ceryle Pharmatech Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Ceryle Pharmatech Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ceryle Pharmatech Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ceryle Pharmatech Llp an active company?

Ceryle Pharmatech Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Ceryle Pharmatech Llp financially healthy?

Processed financial statements are not yet available for Ceryle Pharmatech Llp, so its financial health is unassessed.

Should I do business with Ceryle Pharmatech Llp?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ceryle Pharmatech Llp?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Ceryle Pharmatech Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ceryle Pharmatech Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Ceryle Pharmatech Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.